Strides Gets Usfda Nod For Generic Oxybutynin Chloride Tablets

Strides Gets Usfda Nod For Generic Oxybutynin Chloride Tablets

By, Admin 23 December 2020

Drug Firm Strides Pharma Science On Friday Said Its Singapore-Based Arm Has Received Approval From The Us Health Regulator For Generic Oxybutynin Chloride Tablets Used To Treat Symptoms Of Overactive Bladder And Urinary Incontinence.Company'S Step-Down Wholly Owned Subsidiary Strides Pharma Global Pte Ltd, Singapore, Has Received Approval For Oxybutynin Chloride Tablets Usp, 5 Mg From The United States Food &Amp; Drug Administration (Usfda), Strides Said In A Filing To Bse.The Product Is A Generic Version Of Janssen Pharmaceuticals Inc'S Ditropan Tablets In The Same Strength, It Added. The Product Will Be Manufactured At The Company'S Flagship Facility At Bengaluru And Will Be Marketed By Strides Pharma Inc In The Us Market, Strides Said."According To Iqvia Mat October 2020 Data, The Us Market For Oxybutynin Chloride Tablets Usp, 5 Mg Is Approximately Usd 29 Million", It Added.The Company Has 127 Cumulative Abbreviated New Drug Application (Anda) Filings With Usfda Of Which 94 Andas Have Been Approved And 33 Are Pending Approval, The Filing Said.Shares Of Strides Pharma Science Were Trading At Rs 785.75 Per Scrip On Bse, Up 1.90 Per Cent From Its Previous Close.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!